FBIOX vs. XBI
Compare and contrast key facts about Fidelity Select Biotechnology Portfolio (FBIOX) and SPDR S&P Biotech ETF (XBI).
FBIOX is managed by Fidelity. It was launched on Dec 16, 1985. XBI is a passively managed fund by State Street that tracks the performance of the S&P Biotechnology Select Industry Index. It was launched on Feb 6, 2006.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FBIOX or XBI.
Correlation
The correlation between FBIOX and XBI is 0.94, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
FBIOX vs. XBI - Performance Comparison
Key characteristics
FBIOX:
0.73
XBI:
0.41
FBIOX:
1.12
XBI:
0.74
FBIOX:
1.14
XBI:
1.09
FBIOX:
0.36
XBI:
0.20
FBIOX:
2.65
XBI:
1.29
FBIOX:
5.89%
XBI:
8.18%
FBIOX:
21.37%
XBI:
25.90%
FBIOX:
-71.96%
XBI:
-63.89%
FBIOX:
-35.07%
XBI:
-47.44%
Returns By Period
In the year-to-date period, FBIOX achieves a 7.48% return, which is significantly higher than XBI's 2.37% return. Over the past 10 years, FBIOX has underperformed XBI with an annualized return of -0.29%, while XBI has yielded a comparatively higher 4.32% annualized return.
FBIOX
7.48%
-3.88%
0.69%
13.75%
-2.70%
-0.29%
XBI
2.37%
-3.20%
-1.05%
4.32%
-1.28%
4.32%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FBIOX vs. XBI - Expense Ratio Comparison
FBIOX has a 0.69% expense ratio, which is higher than XBI's 0.35% expense ratio.
Risk-Adjusted Performance
FBIOX vs. XBI - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Biotechnology Portfolio (FBIOX) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
FBIOX vs. XBI - Dividend Comparison
FBIOX's dividend yield for the trailing twelve months is around 0.34%, more than XBI's 0.14% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBIOX Fidelity Select Biotechnology Portfolio | 0.34% | 0.45% | 0.00% | 0.17% | 0.26% | 0.15% | 0.00% | 0.00% | 0.00% | 6.71% | 10.77% | 0.25% |
XBI SPDR S&P Biotech ETF | 0.14% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% | 1.07% | 0.17% |
Drawdowns
FBIOX vs. XBI - Drawdown Comparison
The maximum FBIOX drawdown since its inception was -71.96%, which is greater than XBI's maximum drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for FBIOX and XBI. For additional features, visit the drawdowns tool.
Volatility
FBIOX vs. XBI - Volatility Comparison
The current volatility for Fidelity Select Biotechnology Portfolio (FBIOX) is 7.25%, while SPDR S&P Biotech ETF (XBI) has a volatility of 7.92%. This indicates that FBIOX experiences smaller price fluctuations and is considered to be less risky than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.